Society for the Study of Inborn Errors of Metabolism

Society for the Study of Inborn Errors of Metabolism
Name	Society for the Study of Inborn Errors of Metabolism
Founded	1960s
Headquarters	London
Type	Professional association
Focus	Inborn errors of metabolism, metabolic disorders, pediatric biochemistry

Contents

Society for the Study of Inborn Errors of Metabolism is an international professional association devoted to the study, diagnosis, treatment, and prevention of phenylketonuria, maple syrup urine disease, homocystinuria, lysosomal storage disease, and other inherited metabolic disorders. The Society fosters collaboration among clinicians, researchers, and laboratory scientists from institutions such as Great Ormond Street Hospital, Addenbrooke's Hospital, Mayo Clinic, Johns Hopkins Hospital, and Massachusetts General Hospital while interacting with policy bodies like World Health Organization and funding agencies including Wellcome Trust and National Institutes of Health.

History

The Society emerged in the 1960s amid advances at centers including Toronto General Hospital, Harvard Medical School, University of California, San Francisco, and University of Cambridge that followed discoveries by figures associated with Archibald Garrod, Asbjørn Følling, Viktor Mayer-Rokitansky, Robert Guthrie, and A. J. Gibbs. Early meetings featured investigators from Karolinska Institutet, Institut Pasteur, University of Pennsylvania, and University of Oxford and reflected parallel developments in newborn screening initiatives exemplified by the Guthrie test and programs in Newborn screening in the United States and Newborn screening in the United Kingdom. The Society's governance evolved with influence from leaders at Royal Free Hospital, St Thomas' Hospital, Children's Hospital of Philadelphia, and Boston Children's Hospital, and it established a secretariat in coordination with organizations such as European Society for Paediatric Research and International Federation of Clinical Chemistry and Laboratory Medicine.

The Society's mission aligns with objectives promoted by World Health Organization and United Nations Children's Fund: to advance understanding of inherited metabolic diseases, to standardize diagnostic assays developed at laboratories like Metabolic Unit, Great Ormond Street Hospital, and to translate discoveries akin to those at Salk Institute and Cold Spring Harbor Laboratory into clinical care. Objectives include promoting research funding from bodies such as National Institutes of Health, European Research Council, and Medical Research Council (United Kingdom), supporting training programs modeled on curricula at University College London and Yale School of Medicine, and advocating for newborn screening policies similar to initiatives in Ontario and California.

Membership comprises pediatricians, biochemical geneticists, enzymologists, dietitians, genetic counselors, and laboratory scientists affiliated with institutions including University of Toronto, Imperial College London, Stanford University School of Medicine, and Karolinska University Hospital. The Society is organized into committees reflecting functions seen in organizations like Royal Society, American Academy of Pediatrics, and European Society of Human Genetics: an executive committee, a scientific advisory board, education and training committee, and policy and ethics group. Membership categories parallel those of American College of Medical Genetics and Genomics and include fellows, associate members, and trainee affiliates, with eligibility criteria comparable to licensure standards at General Medical Council and certification practices at American Board of Medical Genetics and Genomics.

The Society convenes annual scientific meetings and biennial symposia hosted at venues such as ExCeL London, Geneva International Conference Centre, Boston Convention and Exhibition Center, and Palais des Congrès de Paris. Programs feature plenary lectures by investigators from Stanford University, University of California, Los Angeles, University of Cambridge, and Karolinska Institutet, workshops on laboratory methods developed at Centers for Disease Control and Prevention, and joint sessions with societies like European Society for Paediatric Research, International Congress of Human Genetics, and American Society of Human Genetics. Proceedings often highlight multicenter trials run with partners including Children's Hospital of Philadelphia, SickKids Hospital, and Vanderbilt University Medical Center.

The Society promotes basic and translational research spanning enzymology studies performed at Max Planck Institute for Biochemistry, metabolomics research pioneered at Broad Institute, and gene therapy trials conducted at National Institute of Neurological Disorders and Stroke affiliates. Educational activities include postgraduate courses modeled on programs at University of Oxford, webinars in collaboration with Royal College of Paediatrics and Child Health, and guideline development echoing standards from National Institute for Health and Care Excellence and American College of Medical Genetics and Genomics. The Society supports trainee exchange fellowships with centers like King's College London, University of Melbourne, Tokyo University Hospital, and coordinates registries comparable to efforts by European Reference Networks and Orphanet.

The Society confers awards recognizing lifetime achievement, early career innovation, and bench-to-bedside translation, analogous to honors from Royal Society, Howard Hughes Medical Institute, and Lasker Foundation. Recipients have included investigators from Massachusetts Institute of Technology, University of California, San Diego, Yale University, University of Edinburgh, and McGill University whose work parallels discoveries honored by the Nobel Prize and the Gairdner Foundation International Award. The Society also issues travel grants and mentorship awards comparable to programs at Wellcome Trust and European Molecular Biology Organization.

Collaborations extend to academic centres such as Johns Hopkins University, University of Toronto, and Karolinska Institutet and to policy partners including World Health Organization and European Commission. The Society's guidelines and consensus statements have influenced newborn screening panels in jurisdictions like Ontario, California, and United Kingdom Department of Health and Social Care and informed clinical protocols at Great Ormond Street Hospital, Boston Children's Hospital, and Mayo Clinic. Collaborative research consortia involving European Molecular Biology Laboratory, Broad Institute, and National Institutes of Health have accelerated enzyme replacement therapies and gene therapies later trialed in facilities such as National Institutes of Health Clinical Center and Children's Hospital Los Angeles, shaping diagnostic algorithms used by laboratories aligned with Clinical and Laboratory Standards Institute.

Category:Medical associations Category:Genetics organizations Category:Rare disease organizations